Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shen Hai Long Capsule for Male Asthenospermia
ChiCTR2300068385Phase 4Not yet recruiting
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Feb 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Shen Hai Long in asthenospermia (2 arms), sponsored by Zhongnan Hospital of Wuhan University. Primary endpoint: Forward progressive motile sperm ratio (PR). Planned start Feb 2023; status: not yet recruiting.
02
Drugs
Shen Hai Long
03
Conditions
asthenospermia
Beyond the preview
Go deeper on ChiCTR2300068385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068385.